Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma

References

• Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet (London, England). 2019;394(10207):1467–1480.
   PubMed Web of Science ®Google Scholar
• Ladabaum U, Dominitz JA, Kahi C, et al. Strategies for colorectal cancer screening. Gastroenterology. 2020;158(2):418–432.
   PubMed Web of Science ®Google Scholar
• Van Schaeybroeck S, Allen WL, Turkington RC, et al. Implementing prognostic and predictive biomarkers in CRC clinical trials. Nat Rev Clin Oncol. 2011;8(4):222–232.
   PubMed Web of Science ®Google Scholar
• Kaminski MF, Robertson DJ, Senore C, et al. Optimizing the quality of colorectal cancer screening worldwide. Gastroenterology. 2020;158(2):404–417.
   PubMed Web of Science ®Google Scholar
• Pang SW, Awi NJ, Armon S, et al. Current update of laboratory molecular diagnostics advancement in management of colorectal cancer (CRC). Diagnostics (Basel, Switzerland). 2019;10(1):9.
   Google Scholar
• Wang Y, Liu Y, Guan Y, et al. Integrated analysis of immune-related genes in endometrial carcinoma. Cancer Cell Int. 2020;20:477.
   PubMed Web of Science ®Google Scholar
• Le Goux C, Vacher S, Schnitzler A, et al. Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer. Sci Rep. 2020;10(1):16641.
   PubMed Web of Science ®Google Scholar
• Huang Y, Liu Z, Zhong L, et al. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients. BMC Genomics. 2020;21(1):691.
   PubMed Web of Science ®Google Scholar
• Zhang D, Yang S, Li Y, et al. Prediction of overall survival among female patients with breast cancer using a prognostic signature based on 8 DNA repair-related genes. JAMA Netw Open. 2020;3(10):e2014622.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550.
   PubMed Web of Science ®Google Scholar
• Pascale RM, Calvisi DF, Simile MM, et al. The Warburg effect 97 years after its discovery. Cancers. 2020;12(10):2819.
   Web of Science ®Google Scholar
• Birkeland ES, Koch LM, Dechant R. Another consequence of the Warburg effect? metabolic regulation of Na+/H + exchangers may link aerobic glycolysis to cell growth. Front Oncol. 2020;10:1561.
   PubMed Web of Science ®Google Scholar
• Talluri B, Amar K, Saul M, et al. COL2A1 is a novel biomarker of melanoma tumor repopulating cells. Biomedicines. 2020;8(9):360.
   Web of Science ®Google Scholar
• Shi Y, Zhang Y, Ran F, et al. Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through GLUT12-mediated Warburg effect. Cancer Lett. 2020;495:53–65.
   PubMed Web of Science ®Google Scholar
• Chen L, Cao Y, Wu B, et al. MicroRNA-3666 suppresses cell growth in head and neck squamous cell carcinoma through inhibition of PFKFB3-mediated Warburg effect. Onco Targets Ther. 2020;13:9029–9041.
   PubMed Web of Science ®Google Scholar
• Xia L, Sun J, Xie S, et al. PRKAR2B-HIF-1α loop promotes aerobic glycolysis and tumour growth in prostate cancer. Cell Prolif. 2020;53(11):e12918.
   PubMed Web of Science ®Google Scholar
• Yang Z, Huang R, Wei X, et al. The SIRT6-autophagy-warburg effect axis in papillary thyroid cancer. Front Oncol. 2020;10:1265.
   PubMed Web of Science ®Google Scholar
• Luo Y, Medina Bengtsson L, Wang X, et al. UQCRH downregulation promotes Warburg effect in renal cell carcinoma cells. Sci Rep. 2020;10(1):15021.
   PubMed Web of Science ®Google Scholar
• Kennedy C, Sebire K, de Kretser DM, et al. Human sperm associated antigen 4 (SPAG4) is a potential cancer marker. Cell Tissue Res. 2004;315(2):279–283.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Y, Liu F. A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma. Int J Mol Med. 2018;42(6):3105–3114.
   PubMed Web of Science ®Google Scholar
• Tian G, Li G, Liu P, et al. Glycolysis-based genes associated with the clinical outcome of pancreatic ductal adenocarcinoma identified by the cancer genome atlas data analysis. DNA Cell Biol. 2020;39(3):417–427.
   PubMed Web of Science ®Google Scholar
• Zhao J, Liu B, Yang JA, et al. Human sperm-associated antigen 4 as a potential biomarker of glioblastoma progression and prognosis. Neuroreport. 2019;30(6):446–451.
   PubMed Web of Science ®Google Scholar
• Yang B, Etheridge T, McCormick J, et al. Validation of an epigenetic field of susceptibility to detect significant prostate cancer from non-tumor biopsies. Clin Epigenet. 2019;11(1):168.
   PubMed Web of Science ®Google Scholar
• Knaup KX, Monti J, Hackenbeck T, et al. Hypoxia regulates the sperm associated antigen 4 (SPAG4) via HIF, which is expressed in renal clear cell carcinoma and promotes migration and invasion in vitro. Mol Carcinog. 2014;53(12):970–978.
   PubMed Web of Science ®Google Scholar
• Shoji K, Murayama T, Mimura I, et al. Sperm-associated antigen 4, a novel hypoxia-inducible factor 1 target, regulates cytokinesis, and its expression correlates with the prognosis of renal cell carcinoma. Am J Pathol. 2013;182(6):2191–2203.
   PubMed Web of Science ®Google Scholar
• Gilkes DM, Bajpai S, Chaturvedi P, et al. Hypoxia-inducible factor 1 (HIF-1) promotes extracellular matrix remodeling under hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts. J Biol Chem. 2013;288(15):10819–10829.
   PubMed Web of Science ®Google Scholar
• Sørensen BS, Toustrup K, Horsman MR, et al. Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro. Acta Oncol. 2010;49(7):895–905.
   PubMed Web of Science ®Google Scholar
• Li Q, Shen Z, Wu Z, et al. High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent-free survival in head and neck squamous cell carcinoma. J Clin Lab Anal. 2020;34(3):e23107.
   PubMed Web of Science ®Google Scholar
• Eriksson J, Le Joncour V, Jahkola T, et al. Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas, and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls. Mol Oncol. 2020;14(4):742–762.
   PubMed Web of Science ®Google Scholar
• Li M, Wu F, Zheng Q, et al. Identification of potential diagnostic and prognostic values of P4HA1 expression in lung cancer, breast cancer, and head and neck cancer. DNA Cell Biol. 2020;39(5):909–917.
   PubMed Web of Science ®Google Scholar
• Law AY, Wong CK. Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia. Exp Cell Res. 2010;316(3):466–476.
   PubMed Web of Science ®Google Scholar
• Law AY, Wong CK. Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells. Exp Cell Res. 2010;316(20):3425–3434.
   PubMed Web of Science ®Google Scholar
• Lin C, Sun L, Huang S, et al. STC2 is a potential prognostic biomarker for pancreatic cancer and promotes migration and invasion by inducing epithelial-mesenchymal transition. Biomed Res Int. 2019;2019:8042489.
   PubMedGoogle Scholar
• He H, Qie S, Guo Q, et al. Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cells. Cancer Manag Res. 2019;11:6411–6424.
   PubMed Web of Science ®Google Scholar
• Pan X, Wu H, Chen G, et al. Prognostic value of enolase gene family in Colon cancer. Med Sci Monit. 2020;26:e922980.
   PubMed Web of Science ®Google Scholar
• Oh S, Yeom J, Cho HJ, et al. Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities. Nat Commun. 2020;11(1):3288.
   PubMed Web of Science ®Google Scholar
• Li J, Chen Y, Guo X, et al. GPC1 exosome and its regulatory miRNAs are specific markers for the detection and target therapy of colorectal cancer. J Cell Mol Med. 2017;21(5):838–847.
   PubMed Web of Science ®Google Scholar